US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lineage

40.80

-0.8100-1.95%

Post-market: 40.800.00000.00%19:30 EDT

Volume:844.46K

Turnover:34.85M

Market Cap:9.26B

PE:-56.67

High:42.28

Open:41.53

Low:40.78

Close:41.61

52wk High:45.75

52wk Low:31.33

Shares:227.08M

Float Shares:57.19M

Volume Ratio:1.30

T/O Rate:1.48%

Dividend:2.12

Dividend Rate:5.19%

EPS(TTM):-0.7200

EPS(LYR):-0.4300

ROE:-2.04%

ROA:0.75%

PB:1.17

PE(LYR):-94.88

Loading ...

Overview Company News Filings

Lineage Cell Therapeutics management to meet with B. Riley

Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)

KARMAN LINE ACQUISITION CORP. Announces Pricing of $200 Million Initial Public Offering

Lineage Seen Benefiting From Improving Industry Conditions, RBC Capital Markets Says

MT Newswires Live

RBC Raises Price Target on Lineage to $48 From $44, Keeps Outperform Rating

MT Newswires Live

Lineage, Inc. : RBC Raises Target Price to $48 from $44

THOMSON REUTERS

Should Widening Losses Despite Higher Sales in Q2 2026 Require Action From Lineage (LINE) Investors?

Simply Wall St.

Lineage is Maintained at Neutral by Citigroup

Lineage Maintained at Buy with Unchanged $3 Target as Cell Therapy Pipeline and DOSED SCI Trial Advance

Lineage CFO Robb LeMasters Buys 20,000 Shares for $826,638

Lineage, Inc. Earnings Call Signals Cautious Upside

Stronger NOI Guidance Amid Wider Losses Could Be A Game Changer For Lineage (LINE)

Simply Wall St.

Lineage Cell Therapeutics Balances Progress and Risk

Lineage Cell Therapeutics reports Q2 EPS (3c), consensus (3c)

Lineage Cell Therapeutics Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.069M Miss $1.531M Estimate

Benzinga Earnings

Press Release: Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and Lineage, Inc. (LINE)

Lineage price target raised to $43 from $40 at Baird

Lineage, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Lineage raises FY26 AFFO view to $2.80-$3.05 from $2.75-$3.00

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LINE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LINE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LINE\",,,,,undefined,":{"symbol":"LINE","market":"US","secType":"STK","nameCN":"Lineage","latestPrice":40.8,"timestamp":1787601600000,"preClose":41.61,"halted":0,"volume":844462,"hourTrading":{"tag":"盘后","latestPrice":40.8,"preClose":40.8,"latestTime":"19:30 EDT","volume":18253,"amount":744741.7334,"timestamp":1787614204940,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.019466474405191114,"floatShares":57192700,"shares":227080326,"eps":-0.72,"marketStatus":"Closed","change":-0.81,"latestTime":"08-24 16:00:00 EDT","open":41.53,"high":42.28,"low":40.78,"amount":34854496.858247995,"amplitude":0.036049,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.72,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"listingDate":1721880000000,"exchange":"NASDAQ","adjPreClose":41.61,"dividendRate":0.051926,"preHourTrading":{"tag":"盘前","latestPrice":41.31,"preClose":41.61,"latestTime":"09:28 EDT","volume":1293,"amount":54390.294549,"timestamp":1787578081064,"change":-0.3,"changeRate":-0.00721,"amplitude":0.031002},"postHourTrading":{"tag":"盘后","latestPrice":40.8,"preClose":40.8,"latestTime":"19:30 EDT","volume":18253,"amount":744741.7334,"timestamp":1787614204940,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.304207,"impliedVol":0.3791,"impliedVolPercentile":0.1235},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LINE\",,,,,undefined,":{"symbol":"LINE","floatShares":57192700,"roa":"0.75%","roe":"-2.04%","lyrEps":-0.43,"volumeRatio":1.304207,"shares":227080326,"dividePrice":2.1186,"high":42.28,"amplitude":0.036049,"preClose":41.61,"low":40.78,"week52Low":31.33,"pbRate":"1.17","psRate":"1.72","week52High":45.75,"institutionHeld":0.1784,"latestPrice":40.8,"eps":-0.72,"divideRate":0.051926,"volume":844462,"delay":0,"ttmEps":-0.72,"open":41.53,"prevYearClose":35,"prevWeekClose":41.61,"prevMonthClose":42.37,"prevQuarterClose":43.25,"fiveDayClose":40.8,"twentyDayClose":42.55,"sixtyDayClose":43.92,"dividendFrequency":"Q","dividendGrowthYears":1,"dividendGrowthRate":1.325068870523416,"fiveYearAvgDividendRate":0.03742366643362218},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LINE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"LINE","fiscalQuarterEnding":"2026/06","expectedEps":0.61,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":0.76},{"date":"2026-06-30","symbol":"LINE","amount":0.5325,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-30","defaultRemindTime":1782826200000,"name":"Lineage","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-21","payableDate":"2026-06-30","currency":"USD","dateTimestamp":1782792000000,"payDate":"2026-07-21"},{"market":"US","date":"2026-05-06","symbol":"LINE","fiscalQuarterEnding":"2026/03","expectedEps":0.58,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"pre","actualEps":0.78},{"date":"2026-03-31","symbol":"LINE","amount":0.5325,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-31","defaultRemindTime":1774963800000,"name":"Lineage","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-21","payableDate":"2026-03-31","currency":"USD","dateTimestamp":1774929600000,"payDate":"2026-04-21"},{"market":"US","date":"2026-02-25","symbol":"LINE","fiscalQuarterEnding":"2025/12","expectedEps":0.59,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"pre","actualEps":0.83}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LINE\",market:\"US\",,,undefined,":[{"executeDate":"2024-09-30","recordDate":"2024-09-30","paymentDate":"2024-10-21","value":0.38,"currency":"USD"},{"executeDate":"2024-12-31","recordDate":"2024-12-31","paymentDate":"2025-01-21","value":0.5275,"currency":"USD"},{"executeDate":"2025-03-31","recordDate":"2025-03-31","paymentDate":"2025-04-21","value":0.5275,"currency":"USD"},{"executeDate":"2025-06-30","recordDate":"2025-06-30","paymentDate":"2025-07-21","value":0.5275,"currency":"USD"},{"executeDate":"2025-09-30","recordDate":"2025-09-30","paymentDate":"2025-10-21","value":0.5275,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LINE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.05,"buy":0.25,"hold":0.5,"sell":0.2,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5,"analysts":20,"updateTime":1785470400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LINE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LINE","date":"2026-08-21","current":-56.666667,"percent":0.366603,"low":-150.19606,"twenty":-81.403755,"median":-44.271421,"eighty":-16.802244,"high":-14.964597,"avg":-47.400817,"sd":33.712452,"marketCap":9440857097},"quantilePoints":[{"date":"2024-07-26","current":-135.297148,"twenty":-133.240266,"median":-129.59991,"eighty":-127.33081,"marketCap":18224525800},{"date":"2024-08-02","current":-145.820923,"twenty":-146.760391,"median":-140.374056,"eighty":-130.053731,"marketCap":19642078377},{"date":"2024-08-09","current":-149.178586,"twenty":-148.252685,"median":-145.575034,"eighty":-133.925893,"marketCap":20094355563},{"date":"2024-08-16","current":-142.403908,"twenty":-146.770565,"median":-143.819892,"eighty":-138.343293,"marketCap":19181806393},{"date":"2024-08-23","current":-98.688122,"twenty":-146.923186,"median":-143.404424,"eighty":-130.053731,"marketCap":19540248095},{"date":"2024-08-30","current":-96.480231,"twenty":-146.227913,"median":-142.463261,"eighty":-98.833015,"marketCap":19103085705},{"date":"2024-09-06","current":-93.156895,"twenty":-146.119382,"median":-140.374056,"eighty":-96.954008,"marketCap":18445065232},{"date":"2024-09-13","current":-95.732768,"twenty":-145.993894,"median":-129.59991,"eighty":-95.649972,"marketCap":18955088021},{"date":"2024-09-20","current":-93.087899,"twenty":-145.732742,"median":-99.424085,"eighty":-94.909408,"marketCap":18431403907},{"date":"2024-09-27","current":-90.02905,"twenty":-145.49194,"median":-98.486882,"eighty":-94.26544,"marketCap":17825751846},{"date":"2024-10-04","current":-88.39613,"twenty":-144.725443,"median":-96.871212,"eighty":-93.115497,"marketCap":17502433828},{"date":"2024-10-11","current":-86.556221,"twenty":-143.487517,"median":-95.865011,"eighty":-90.408531,"marketCap":17138131836},{"date":"2024-10-18","current":-89.178092,"twenty":-142.853292,"median":-95.28429,"eighty":-88.708915,"marketCap":17657262174},{"date":"2024-10-25","current":-87.671666,"twenty":-142.575183,"median":-94.927808,"eighty":-88.455927,"marketCap":17358989918},{"date":"2024-11-01","current":-83.106392,"twenty":-142.43952,"median":-94.755316,"eighty":-88.014349,"marketCap":16455065601},{"date":"2024-11-08","current":-23.853641,"twenty":-141.591967,"median":-94.082599,"eighty":-87.618769,"marketCap":15361744673},{"date":"2024-11-15","current":-22.510722,"twenty":-138.343293,"median":-93.156895,"eighty":-86.629817,"marketCap":14496904918},{"date":"2024-11-22","current":-22.712691,"twenty":-133.925893,"median":-92.24269,"eighty":-85.252186,"marketCap":14626973166},{"date":"2024-11-29","current":-22.471745,"twenty":-130.961371,"median":-90.805262,"eighty":-83.56407,"marketCap":14471804028},{"date":"2024-12-06","current":-22.011114,"twenty":-127.33081,"median":-90.02905,"eighty":-23.887657,"marketCap":14175157147},{"date":"2024-12-13","current":-21.97568,"twenty":-121.749465,"median":-89.580572,"eighty":-23.012456,"marketCap":14152338156},{"date":"2024-12-20","current":-20.753234,"twenty":-99.32519,"median":-88.545623,"eighty":-22.64466,"marketCap":13365082970},{"date":"2024-12-27","current":-20.905597,"twenty":-98.92961,"median":-88.258137,"eighty":-22.510722,"marketCap":13463204631},{"date":"2025-01-03","current":-20.905597,"twenty":-98.73642,"median":-88.20064,"eighty":-22.420722,"marketCap":13463204631},{"date":"2025-01-10","current":-19.654805,"twenty":-98.446634,"median":-87.890155,"eighty":-22.273319,"marketCap":12657694252},{"date":"2025-01-17","current":-20.615045,"twenty":-97.561177,"median":-87.625669,"eighty":-22.140799,"marketCap":13276088905},{"date":"2025-01-24","current":-21.245756,"twenty":-96.995405,"median":-87.407179,"eighty":-21.811979,"marketCap":13682266943},{"date":"2025-01-31","current":-21.259929,"twenty":-96.71482,"median":-86.556221,"eighty":-21.261347,"marketCap":13691394540},{"date":"2025-02-07","current":-20.522919,"twenty":-96.287041,"median":-85.872006,"eighty":-21.229457,"marketCap":13216759529},{"date":"2025-02-14","current":-19.973704,"twenty":-95.89146,"median":-85.084294,"eighty":-20.979298,"marketCap":12863065170},{"date":"2025-02-21","current":-19.091417,"twenty":-95.705169,"median":-83.416877,"eighty":-20.860243,"marketCap":12294872296},{"date":"2025-02-28","current":-20.706163,"twenty":-95.532678,"median":-24.073327,"eighty":-20.758903,"marketCap":13748892325},{"date":"2025-03-07","current":-21.053271,"twenty":-95.272791,"median":-23.651671,"eighty":-20.753234,"marketCap":13979371682},{"date":"2025-03-14","current":-20.118486,"twenty":-95.185395,"median":-23.100685,"eighty":-20.713451,"marketCap":13358674800},{"date":"2025-03-21","current":-20.070372,"twenty":-94.983005,"median":-22.840251,"eighty":-20.684293,"marketCap":13326727167},{"date":"2025-03-28","current":-20.269701,"twenty":-94.831212,"median":-22.58336,"eighty":-20.618588,"marketCap":13459081649},{"date":"2025-04-04","current":-18.678506,"twenty":-94.801314,"median":-22.510722,"eighty":-20.546012,"marketCap":12402527766},{"date":"2025-04-11","current":-18.45512,"twenty":-94.693219,"median":-22.452257,"eighty":-20.399959,"marketCap":12254199467},{"date":"2025-04-17","current":-19.214632,"twenty":-94.444831,"median":-22.33887,"eighty":-20.283448,"marketCap":12758515683},{"date":"2025-04-25","current":-19.194012,"twenty":-94.145846,"median":-22.252059,"eighty":-20.149417,"marketCap":12744823840},{"date":"2025-05-02","current":-16.587441,"twenty":-94.019352,"median":-22.179422,"eighty":-20.037483,"marketCap":10350562942},{"date":"2025-05-09","current":-16.711993,"twenty":-93.904358,"median":-22.011114,"eighty":-19.920554,"marketCap":10428283601},{"date":"2025-05-16","current":-17.448317,"twenty":-93.156895,"median":-21.581486,"eighty":-19.676065,"marketCap":10887749844},{"date":"2025-05-23","current":-16.71932,"twenty":-93.087899,"median":-21.263473,"eighty":-19.558303,"marketCap":10432855404},{"date":"2025-05-30","current":-16.092895,"twenty":-92.811913,"median":-21.249299,"eighty":-19.409177,"marketCap":10041966212},{"date":"2025-06-06","current":-16.096558,"twenty":-91.942555,"median":-21.231583,"eighty":-19.343951,"marketCap":10044252113},{"date":"2025-06-13","current":-16.646053,"twenty":-91.006502,"median":-21.199693,"eighty":-19.183414,"marketCap":10387137370},{"date":"2025-06-20","current":-16.320019,"twenty":-90.801812,"median":-21.08985,"eighty":-19.019731,"marketCap":10183692118},{"date":"2025-06-27","current":-16.429919,"twenty":-90.394732,"median":-20.934756,"eighty":-18.674382,"marketCap":10252269169},{"date":"2025-07-03","current":-15.946362,"twenty":-90.091147,"median":-20.886643,"eighty":-18.14994,"marketCap":9950530143},{"date":"2025-07-11","current":-15.77785,"twenty":-90.01985,"median":-20.860815,"eighty":-17.486415,"marketCap":9845378664},{"date":"2025-07-18","current":-15.191722,"twenty":-89.932455,"median":-20.808156,"eighty":-17.309844,"marketCap":9479634391},{"date":"2025-07-25","current":-15.847453,"twenty":-89.62887,"median":-20.753234,"eighty":-16.815894,"marketCap":9888810797},{"date":"2025-08-01","current":-15.807157,"twenty":-89.274687,"median":-20.746147,"eighty":-16.701003,"marketCap":9863665878},{"date":"2025-08-08","current":-17.422161,"twenty":-88.925104,"median":-20.723347,"eighty":-16.650449,"marketCap":9791254435},{"date":"2025-08-15","current":-16.376017,"twenty":-88.485826,"median":-20.675311,"eighty":-16.612351,"marketCap":9203321634},{"date":"2025-08-22","current":-15.911969,"twenty":-88.340933,"median":-20.632761,"eighty":-16.564012,"marketCap":8942526539},{"date":"2025-08-29","current":-16.913336,"twenty":-88.248937,"median":-20.61249,"eighty":-16.564012,"marketCap":9505294901},{"date":"2025-09-05","current":-16.469641,"twenty":-88.228238,"median":-20.558384,"eighty":-16.562905,"marketCap":9255938188},{"date":"2025-09-12","current":-17.255266,"twenty":-88.138543,"median":-20.506834,"eighty":-16.558867,"marketCap":9697459708},{"date":"2025-09-19","current":-16.481853,"twenty":-87.890155,"median":-20.358154,"eighty":-16.558867,"marketCap":9262801217},{"date":"2025-09-26","current":-15.264744,"twenty":-87.846457,"median":-20.283448,"eighty":-16.472083,"marketCap":8578786012},{"date":"2025-10-03","current":-16.294605,"twenty":-87.669366,"median":-20.179217,"eighty":-16.412335,"marketCap":9157568108},{"date":"2025-10-10","current":-16.29257,"twenty":-87.646368,"median":-20.118486,"eighty":-16.399147,"marketCap":9156424270},{"date":"2025-10-17","current":-16.705736,"twenty":-87.575071,"median":-20.053928,"eighty":-16.38218,"marketCap":9388623412},{"date":"2025-10-24","current":-16.319029,"twenty":-87.469276,"median":-19.998201,"eighty":-16.325134,"marketCap":9171294166},{"date":"2025-10-31","current":-15.883475,"twenty":-87.19099,"median":-19.887207,"eighty":-16.319227,"marketCap":8926512805},{"date":"2025-11-07","current":-46.25122,"twenty":-86.703414,"median":-19.85386,"eighty":-16.305168,"marketCap":8186465952},{"date":"2025-11-14","current":-43.02679,"twenty":-86.540122,"median":-19.985953,"eighty":-16.319029,"marketCap":7615741890},{"date":"2025-11-21","current":-42.652756,"twenty":-86.445827,"median":-20.037483,"eighty":-16.319227,"marketCap":7549537898},{"date":"2025-11-28","current":-46.405993,"twenty":-86.326233,"median":-20.115049,"eighty":-16.320019,"marketCap":8213860707},{"date":"2025-12-05","current":-46.431788,"twenty":-85.417778,"median":-20.155459,"eighty":-16.323099,"marketCap":8218426500},{"date":"2025-12-12","current":-47.644174,"twenty":-85.141791,"median":-20.269701,"eighty":-16.333276,"marketCap":8433018747},{"date":"2025-12-19","current":-44.252074,"twenty":-85.084294,"median":-20.331579,"eighty":-16.376017,"marketCap":7832617033},{"date":"2025-12-26","current":-45.245198,"twenty":-84.339131,"median":-20.438748,"eighty":-16.378109,"marketCap":8008400045},{"date":"2026-01-02","current":-45.142016,"twenty":-83.711262,"median":-20.514876,"eighty":-16.389275,"marketCap":7990136875},{"date":"2026-01-09","current":-47.141163,"twenty":-83.230586,"median":-20.579005,"eighty":-16.396717,"marketCap":8343985793},{"date":"2026-01-16","current":-47.025083,"twenty":-62.556492,"median":-20.615045,"eighty":-16.403543,"marketCap":8323439727},{"date":"2026-01-23","current":-45.451561,"twenty":-48.500582,"median":-20.641968,"eighty":-16.416337,"marketCap":8044926385},{"date":"2026-01-30","current":-46.405993,"twenty":-47.884071,"median":-20.678825,"eighty":-16.429329,"marketCap":8213860707},{"date":"2026-02-06","current":-47.386219,"twenty":-47.884071,"median":-20.726783,"eighty":-16.432782,"marketCap":8387360822},{"date":"2026-02-13","current":-48.804968,"twenty":-49.436956,"median":-20.749691,"eighty":-16.440332,"marketCap":8638479410},{"date":"2026-02-20","current":-50.301104,"twenty":-49.630422,"median":-20.753234,"eighty":-16.450102,"marketCap":8903295375},{"date":"2026-02-27","current":-93.0019,"twenty":-50.081842,"median":-20.808156,"eighty":-16.472083,"marketCap":9300190000},{"date":"2026-03-06","current":-91.899408,"twenty":-76.857459,"median":-20.860815,"eighty":-16.489994,"marketCap":9189940793},{"date":"2026-03-13","current":-83.724516,"twenty":-84.898003,"median":-20.886643,"eighty":-16.522559,"marketCap":8372451619},{"date":"2026-03-20","current":-83.45202,"twenty":-85.130292,"median":-20.963916,"eighty":-16.529674,"marketCap":8345201980},{"date":"2026-03-27","current":-76.41253,"twenty":-84.984919,"median":-21.116425,"eighty":-16.558346,"marketCap":7641252969},{"date":"2026-04-02","current":-74.436931,"twenty":-84.587421,"median":-21.205526,"eighty":-16.559194,"marketCap":7443693086},{"date":"2026-04-10","current":-78.274588,"twenty":-84.15284,"median":-21.242213,"eighty":-16.561797,"marketCap":7827458837},{"date":"2026-04-17","current":-82.838903,"twenty":-83.724516,"median":-21.254614,"eighty":-16.567335,"marketCap":8283890292},{"date":"2026-04-24","current":-80.727056,"twenty":-84.15284,"median":-21.298906,"eighty":-16.571406,"marketCap":8072705589},{"date":"2026-05-01","current":-83.769397,"twenty":-84.15284,"median":-21.839263,"eighty":-16.587441,"marketCap":8376939722},{"date":"2026-05-08","current":-62.329756,"twenty":-84.132822,"median":-22.096153,"eighty":-16.591759,"marketCap":9100144369},{"date":"2026-05-15","current":-61.44089,"twenty":-83.769397,"median":-22.213083,"eighty":-16.592936,"marketCap":8970369981},{"date":"2026-05-22","current":-62.454509,"twenty":-83.724516,"median":-22.287493,"eighty":-16.594767,"marketCap":9118358318},{"date":"2026-05-29","current":-68.489439,"twenty":-83.506519,"median":-22.372532,"eighty":-16.629935,"marketCap":9999458110},{"date":"2026-06-05","current":-67.366661,"twenty":-83.423906,"median":-22.484147,"eighty":-16.64023,"marketCap":9835532568},{"date":"2026-06-12","current":-69.503058,"twenty":-83.190661,"median":-22.524895,"eighty":-16.644964,"marketCap":10147446448},{"date":"2026-06-18","current":-64.762441,"twenty":-83.120057,"median":-22.627652,"eighty":-16.652647,"marketCap":9455316378},{"date":"2026-06-26","current":-66.446607,"twenty":-83.108111,"median":-22.859739,"eighty":-16.66672,"marketCap":9701204692},{"date":"2026-07-02","current":-67.974833,"twenty":-83.026341,"median":-23.100685,"eighty":-16.681312,"marketCap":9924325570},{"date":"2026-07-10","current":-68.583004,"twenty":-82.87932,"median":-23.651671,"eighty":-16.693585,"marketCap":10013118572},{"date":"2026-07-17","current":-69.035234,"twenty":-82.793487,"median":-24.073327,"eighty":-16.6985,"marketCap":10079144138},{"date":"2026-07-24","current":-63.857981,"twenty":-82.452867,"median":-42.781734,"eighty":-16.708239,"marketCap":9323265246},{"date":"2026-07-31","current":-66.820867,"twenty":-81.984867,"median":-43.02679,"eighty":-16.713458,"marketCap":9755846540},{"date":"2026-08-07","current":-54.758195,"twenty":-81.729895,"median":-43.413722,"eighty":-16.71932,"marketCap":9254134887},{"date":"2026-08-14","current":-57.978472,"twenty":-81.626294,"median":-44.019915,"eighty":-16.735438,"marketCap":9798361816},{"date":"2026-08-21","current":-55.86306,"twenty":-81.403755,"median":-44.271421,"eighty":-16.802244,"marketCap":9440857097}],"updateTime":1787622283983},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LINE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662120839","title":"Lineage Cell Therapeutics management to meet with B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2662120839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662120839?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:50","pubTimestamp":1787590209,"startTime":"0","endTime":"0","summary":"Meeting to be held on August 25 in San Francisco and in Los Angeles on August 26 hosted by R. Riley. Published first on TheFly – the ultimate sourc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lineage-cell-therapeutics-management-to-meet-with-b-riley-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lineage-cell-therapeutics-management-to-meet-with-b-riley-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4224","LINE","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660280818","title":"Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660280818","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660280818?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:40","pubTimestamp":1787233226,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Harrow Health (HROW) and Lineage, Inc. (LINE). Harrow Health (HROW) In a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-na-companies-harrow-health-hrow-and-lineage-inc-line-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-na-companies-harrow-health-hrow-and-lineage-inc-line-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4141","BK4224","LINE","HROW","BK4007","BK4557","NA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660455432","title":"KARMAN LINE ACQUISITION CORP. Announces Pricing of $200 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2660455432","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660455432?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:46","pubTimestamp":1787017560,"startTime":"0","endTime":"0","summary":"BOCA RATON, Fla., Aug.  17, 2026 (GLOBE NEWSWIRE) -- KARMAN LINE ACQUISITION CORP. (the “Company”), a special purpose acquisition company, today announced the pricing of its initial public offering of","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/18/3346561/0/en/karman-line-acquisition-corp-announces-pricing-of-200-million-initial-public-offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4224","CORP","LINE","BK4550","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660436575","title":"Lineage Seen Benefiting From Improving Industry Conditions, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660436575","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660436575?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:18","pubTimestamp":1786979885,"startTime":"0","endTime":"0","summary":"Lineage  is beginning to benefit from a better operating environment amid easing industry headwinds, RBC Capital Markets said in a note emailed Monday.The investment firm said customer inventory levels appear to be troughing after customers reduced inventories following an unexpected build in late 2022 and early 2023. Pressure from new supply is also starting to abate as the company has been more successful winning customers back, analysts said.Trade disruption, which accounts for about 15% of Lineage's business, has affected throughput but should begin to lap results in Q4, RBC said.The firm said the remaining key risk is that higher inflation could lead food producers to raise prices, potentially affecting future sales volumes and inventory levels.The firm models AFFO estimates of $2.93 per share in 2026, $2.92 in 2027 and $3.17 in 2028.RBC Capital Markets maintained its outperform rating on Lineage and raised its price target to $48 from $44.Price: 41.19, Change: -0.56, Percent Chan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0310800379.SGD","GSIB","LU1267930573.SGD","LINE","BK4207","BK4224","LU0029864427.USD","LU0128525929.USD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660812674","title":"RBC Raises Price Target on Lineage to $48 From $44, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2660812674","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660812674?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:42","pubTimestamp":1786963360,"startTime":"0","endTime":"0","summary":"Lineage (LINE) has an average rating of hold and mean price target of $45.56, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660101361","title":"Lineage, Inc. : RBC Raises Target Price to $48 from $44","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101361","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660101361?lang=en_us&edition=fundamental","pubTime":"2026-08-17 11:06","pubTimestamp":1786936014,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44B2YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LINE","BK4224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659179632","title":"Should Widening Losses Despite Higher Sales in Q2 2026 Require Action From Lineage (LINE) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2659179632","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659179632?lang=en_us&edition=fundamental","pubTime":"2026-08-16 05:20","pubTimestamp":1786828833,"startTime":"0","endTime":"0","summary":"Lineage, Inc. has released its second-quarter and six-month 2026 results, showing sales of US$1,361 million and US$2,658 million respectively, alongside net losses of US$29 million for the quarter and US$75 million for the half-year, both larger than the prior-year periods.\nWhile revenue inched higher year on year, the sharp increase in net loss and loss per share highlights rising cost or margin pressures that investors are likely examining closely.\nWe will now examine how the widening net...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551732-choice1-main-header/1585186732782","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551732-choice1-main-header/1585186732782"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nasdaq-line/lineage/news/should-widening-losses-despite-higher-sales-in-q2-2026-requi","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nasdaq-line/lineage/news/should-widening-losses-despite-higher-sales-in-q2-2026-requi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LINE","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659816229","title":"Lineage is Maintained at Neutral by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2659816229","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659816229?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:09","pubTimestamp":1786651740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LINE/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659902284","title":"Lineage Maintained at Buy with Unchanged $3 Target as Cell Therapy Pipeline and DOSED SCI Trial Advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2659902284","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659902284?lang=en_us&edition=fundamental","pubTime":"2026-08-13 03:05","pubTimestamp":1786561520,"startTime":"0","endTime":"0","summary":"Lineage Therap, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Michael Okunewitch from Maxim Group mainta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/lineage-maintained-at-buy-with-unchanged-3-target-as-cell-therapy-pipeline-and-dosed-sci-trial-advance-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/lineage-maintained-at-buy-with-unchanged-3-target-as-cell-therapy-pipeline-and-dosed-sci-trial-advance-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DOSED","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954080","title":"Lineage CFO Robb LeMasters Buys 20,000 Shares for $826,638","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954080","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954080?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:11","pubTimestamp":1786396260,"startTime":"0","endTime":"0","summary":"Lineage CFO Robb LeMasters buys 20,000 shares for $826,638Lineage CFO Robb A. LeMasters bought 20,000 common shares at USD 41.33, held indirectly via an IRA.Indirect holdings via the IRA rose to 49,50","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL56lpcm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lineage CFO Robb LeMasters Buys 20,000 Shares for $826,638","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE","BK4224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658605225","title":"Lineage, Inc. Earnings Call Signals Cautious Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2658605225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658605225?lang=en_us&edition=fundamental","pubTime":"2026-08-10 08:12","pubTimestamp":1786320731,"startTime":"0","endTime":"0","summary":"Lineage, Inc. (($LINE)) has held its Q2 earnings call. Read on for the main highlights of the call. Lineage, Inc. struck a cautiously upbeat note o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lineage-inc-earnings-call-signals-cautious-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lineage-inc-earnings-call-signals-cautious-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657624416","title":"Stronger NOI Guidance Amid Wider Losses Could Be A Game Changer For Lineage (LINE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657624416","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657624416?lang=en_us&edition=fundamental","pubTime":"2026-08-08 08:26","pubTimestamp":1786148802,"startTime":"0","endTime":"0","summary":"In the past quarter, Lineage, Inc. reported second‑quarter 2026 sales of US$1,361 million, with net loss widening to US$29 million and basic loss per share from continuing operations increasing to US$0.13.\nDespite higher losses for both the quarter and first half of 2026, management highlighted raised full‑year same‑store NOI guidance and improving operational trends, including stronger physical occupancy and geographic diversification.\nWith raised same‑store NOI guidance and plans to reduce...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551732-choice1-main-header/1585186732782","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551732-choice1-main-header/1585186732782"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nasdaq-line/lineage/news/stronger-noi-guidance-amid-wider-losses-could-be-a-game-chan","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nasdaq-line/lineage/news/stronger-noi-guidance-amid-wider-losses-could-be-a-game-chan","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LINE","BK4224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657624909","title":"Lineage Cell Therapeutics Balances Progress and Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2657624909","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657624909?lang=en_us&edition=fundamental","pubTime":"2026-08-08 08:13","pubTimestamp":1786148027,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics, Inc. (($LCTX)) has held its Q2 earnings call. Read on for the main highlights of the call. Lineage Cell Therapeutics’ la...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lineage-cell-therapeutics-balances-progress-and-risk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lineage-cell-therapeutics-balances-progress-and-risk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LINE","BK4539","LENZ","GXDW","JOYT","BK4007","VGFPF","FEBU","LU2065732104.USD","PMDE","RGLO","VOTE","BK4139","DECU","BK4097","PRGS","BK4224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657719650","title":"Lineage Cell Therapeutics reports Q2 EPS (3c), consensus (3c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657719650","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657719650?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:17","pubTimestamp":1786047454,"startTime":"0","endTime":"0","summary":"Reports Q2 revenue $1.069M, consensus $1.53M. “As we continue to support our collaboration with Roche and Genentech for their clinical development ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lineage-cell-therapeutics-reports-q2-eps-3c-consensus-3c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lineage-cell-therapeutics-reports-q2-eps-3c-consensus-3c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657665757","title":"Lineage Cell Therapeutics Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.069M Miss $1.531M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657665757","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657665757?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:02","pubTimestamp":1786046571,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.069M Miss $1.531M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/LCTX","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657465783","title":"Press Release: Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657465783","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657465783?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046460,"startTime":"0","endTime":"0","summary":"--  Positive 3 Year Phase 1/2a Clinical Data of RG6501 . --  Announced Progress with Wholly-Owned Corneal Endothelial Disease Cell. --  Established Scientific Advisory Board With Cell Therapy Executive. --  Cash, cash equivalents, and marketable securities as of June 30, 2026. expected to support planned operations into Q3 2028.results encore featured at Foundation Fighting Blindness' Retinal. Therapeutics Innovation Summit 2026, suggest evidence of sustained gains. in best corrected visual acuity  and partial structural restoration. of the retina, including regions with re-appearance of an RPE layer and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","TM","BK4604","03160","IBB","BK4007","EES","LCTX","BK4022","BK4539","BK4555","BK4224","R","BK4585","BK4232","BK4099","BK4588","SYNB","LINE","WDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657658221","title":"Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and Lineage, Inc. (LINE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657658221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657658221?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:01","pubTimestamp":1786028513,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on GRAIL Inc (GRAL) and Lineage, Inc. (LINE). GRAIL Inc (GRAL) In a report r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-grail-inc-gral-and-lineage-inc-line-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-grail-inc-gral-and-lineage-inc-line-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4224","BK4141","BK4139","LINE","GRAL","NA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657637812","title":"Lineage price target raised to $43 from $40 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2657637812","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657637812?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:41","pubTimestamp":1786023700,"startTime":"0","endTime":"0","summary":"Baird raised the firm’s price target on Lineage (LINE) to $43 from $40 and keeps a Neutral rating on the shares. The firm updated its model followi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lineage-price-target-raised-to-43-from-40-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lineage-price-target-raised-to-43-from-40-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657454053","title":"Lineage, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657454053","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657454053?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:31","pubTimestamp":1785936684,"startTime":"0","endTime":"0","summary":"Lineage, Inc. reports results for the quarter ended June 30 - Earnings SummaryLineage, Inc.LINE.OQreported a quarterly adjusted loss of 13 cents per share for the quarter ended June 30, lower than the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N44222Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE","BK4224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657434225","title":"Lineage raises FY26 AFFO view to $2.80-$3.05 from $2.75-$3.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2657434225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657434225?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:32","pubTimestamp":1785925952,"startTime":"0","endTime":"0","summary":"Consensus is for FY26 AFFO $2.94. Sees FY26 adjusted EBITDA of $1.26B-$1.29B. Published first on TheFly – the ultimate source for real-time, market...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lineage-raises-fy26-affo-view-to-2-80-3-05-from-2-75-3-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lineage-raises-fy26-affo-view-to-2-80-3-05-from-2-75-3-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4224","LINE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":168,"code":"91000000","status":"200"}]}}